Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Pramipexole Dihydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 11,303Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Novast Labs' Generic Pramipexole Dihydrochloride Receives Approval in the U.S.
    Novast Labs' Generic Pramipexole Dihydrochloride Receives Approval in the U.S.

    03 Feb 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213444

    FDA
    03 Feb 2022
    Share Share
    Chase gets cash for pivotal trials in depression, Parkinson's
    Chase gets cash for pivotal trials in depression, Parkinson's

    20 Oct 2021

    // Nick Paul Taylor FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/chase-after-selling-last-biotech-to-allergan-gets-cash-to-start-pivotal-trials-depression

    Nick Paul Taylor FIERCEBIOTECH
    20 Oct 2021
    Share Share
    Enforcement Report - Week of September 18, 2019
    Enforcement Report - Week of September 18, 2019

    18 Sep 2019

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-18-2019-1568770223.pdf

    FDA
    18 Sep 2019
    Share Share
    Watchdog sues FDA for stalling on Parkinson's drug warnings
    Watchdog sues FDA for stalling on Parkinson's drug warnings

    01 May 2019

    // Kyle Blankenship FIERCE PHARMA

    https://www.fiercepharma.com/pharma/public-citizen-says-enough-enough-dopamine-agonist-petition-files-for-injunction

    Kyle Blankenship FIERCE PHARMA
    01 May 2019
    Share Share
    Alembic Pharma gets USFDA nod for Parkinson’s treatment drug
    Alembic Pharma gets USFDA nod for Parkinson’s treatment drug

    03 Jan 2019

    // HINDU BUSINESS LINE

    https://www.thehindubusinessline.com/companies/alembic-pharma-gets-usfda-nod-for-parkinsons-treatment-drug/article25897238.ece

    HINDU BUSINESS LINE
    03 Jan 2019
    Share Share
    Alembic Pharm's Generic Pramipexole Dihydrochloride Receives Approval in US
    Alembic Pharm's Generic Pramipexole Dihydrochloride Receives Approval in US

    02 Jan 2019

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204518

    FDA
    02 Jan 2019
    Share Share